YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson was hit with an $8 billion jury verdict over the marketing of antipsychotic drug Risperdal.
The plaintiff, Nicholas Murray, sued the company in 2013, alleging he grew breasts — a condition known as gynecomastia — after he started using Risperdal when he was 9 years old in 2003. He was using the drug to treat autism symptoms.
The suit accused J&J subsidiary Janssen Pharmaceuticals of improperly marketing the drug as a treatment for certain mental health disorders in children.
Read more from The New York Times.
Connected to Watkins Elementary School is a new storm shelter now under construction.
STL construction firm buys KC company
Updated: Systematic Savings Bank to be acquired in $14M deal
Webster University's deficit triples
Missouri House speaker accused of obstruction in ethics probe
‘Dress for your day’: Companies are relaxing dress codes amid evolving ideas about fashion
Developer targets opening by month's end for $10M apartment complex